Display options
Share it on

PPAR Res. 2010;2010:129173. doi: 10.1155/2010/129173. Epub 2010 Nov 24.

Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism.

PPAR research

Timothy R H Regnault, Lin Zhao, Jacky S S Chiu, Stephanie K Gottheil, Allison Foran, Siu-Pok Yee

Affiliations

  1. Children's Health Research Institute and Lawson Research Institute, Department of Obstetrics and Gynecology, University of Western Ontario, London, ON, Canada N6A 5C1.

PMID: 21113404 PMCID: PMC2991640 DOI: 10.1155/2010/129173

Abstract

PPAR-α, PPAR-β, and PPAR-γ, and RXR in conjunction with PGC-1α and SIRT1, activate oxidative metabolism genes determining insulin sensitivity. In utero, hypoxia is commonly observed in Intrauterine Growth Restriction (IUGR), and reduced insulin sensitivity is often observed in these infants as adults. We sought to investigate how changes in oxygen tension might directly impact muscle PPAR regulation of oxidative genes. Following eight days in culture at 1% oxygen, C(2)C(12) muscle myoblasts displayed a reduction of PGC-1α, PPAR-α, and RXR-α mRNA, as well as CPT-1b and UCP-2 mRNA. SIRT1 and PGC-1α protein was reduced, and PPAR-γ protein increased. The addition of a PPAR-β agonist (L165,041) for the final 24 hours of 1% treatment resulted in increased levels of UCP-2 mRNA and protein whereas Rosiglitazone induced SIRT1, PGC-1α, RXR-α, PPAR-α, CPT-1b, and UCP-2 mRNA and SIRT1 protein. Under hypoxia, Resveratrol induced SIRT1, RXR-α, PPAR-α mRNA, and PPAR-γ and UCP-2 protein. These findings demonstrate that hypoxia alters the components of the PPAR pathway involved in muscle fatty acid oxidative gene transcription and translation. These results have implications for understanding selective hypoxia adaptation and how it might impact long-term muscle oxidative metabolism and insulin sensitivity.

References

  1. J Biol Chem. 2001 Jul 20;276(29):27605-12 - PubMed
  2. Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):487-501 - PubMed
  3. Nature. 2010 Jul 22;466(7305):451-6 - PubMed
  4. Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G364-74 - PubMed
  5. J Physiol. 2007 Dec 15;585(Pt 3):911-7 - PubMed
  6. J Endocrinol. 2010 Feb;204(2):93-104 - PubMed
  7. Cell Metab. 2006 Nov;4(5):407-14 - PubMed
  8. Placenta. 2007 Jul;28(7):714-23 - PubMed
  9. FASEB J. 2003 Dec;17(15):2299-301 - PubMed
  10. J Anim Sci. 2006 Oct;84(10):2655-65 - PubMed
  11. J Clin Endocrinol Metab. 2001 Nov;86(11):5427-32 - PubMed
  12. Cell Mol Life Sci. 2004 Feb;61(4):393-416 - PubMed
  13. Mol Cancer Ther. 2005 Oct;4(10):1465-74 - PubMed
  14. Biochim Biophys Acta. 2000 Jun 1;1475(1):83-9 - PubMed
  15. Nature. 2003 Sep 11;425(6954):191-6 - PubMed
  16. J Reprod Dev. 2005 Feb;51(1):59-68 - PubMed
  17. Cell. 2006 Dec 15;127(6):1109-22 - PubMed
  18. Cancer Res. 1999 Oct 1;59(19):4776-80 - PubMed
  19. Placenta. 2009 Jul;30(7):625-33 - PubMed
  20. Mol Cell Biol. 2005 Apr;25(8):3040-55 - PubMed
  21. Cell Metab. 2007 Oct;6(4):307-19 - PubMed
  22. Biomed Pharmacother. 2008 Nov;62(9):613-21 - PubMed
  23. Diabetologia. 2006 Nov;49(11):2713-22 - PubMed
  24. FASEB J. 2001 Sep;15(11):2033-5 - PubMed
  25. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8466-71 - PubMed
  26. J Cell Biochem. 2008 Apr 1;103(5):1369-78 - PubMed
  27. Neuroscience. 2009 Mar 31;159(3):993-1002 - PubMed
  28. Pediatr Res. 2003 Jun;53(6):994-1000 - PubMed
  29. J Clin Endocrinol Metab. 1997 Feb;82(2):402-6 - PubMed
  30. J Immunol. 2001 Jun 15;166(12):7543-8 - PubMed
  31. Appl Physiol Nutr Metab. 2007 Oct;32(5):874-83 - PubMed
  32. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9029-33 - PubMed
  33. Biol Neonate. 1986;49(2):85-9 - PubMed
  34. J Biol Chem. 2010 Feb 26;285(9):6658-69 - PubMed
  35. J Clin Endocrinol Metab. 2000 Apr;85(4):1401-6 - PubMed
  36. J Clin Invest. 2003 Aug;112(4):608-18 - PubMed
  37. FASEB J. 1998 Jun;12(9):715-24 - PubMed
  38. J Biol Chem. 2008 Aug 15;283(33):22464-72 - PubMed
  39. Physiol Behav. 2006 Jun 30;88(3):234-43 - PubMed
  40. Horm Res. 2005;64 Suppl 3:2-7 - PubMed
  41. J Clin Endocrinol Metab. 2008 Oct;93(10):3885-92 - PubMed
  42. Biochem Biophys Res Commun. 2004 Feb 6;314(2):561-4 - PubMed
  43. Nature. 2004 Jun 17;429(6993):771-6 - PubMed
  44. Recent Prog Horm Res. 2001;56:239-63 - PubMed
  45. Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E514-24 - PubMed
  46. Proc Nutr Soc. 2004 May;63(2):375-80 - PubMed
  47. Mol Endocrinol. 2003 Dec;17(12):2477-93 - PubMed
  48. Neurosci Lett. 2009 Feb 20;451(2):105-8 - PubMed
  49. EMBO J. 2007 Apr 4;26(7):1913-23 - PubMed
  50. Endocr Rev. 2003 Feb;24(1):78-90 - PubMed
  51. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):829-33 - PubMed
  52. Biochem Biophys Res Commun. 2007 Dec 21;364(3):567-72 - PubMed
  53. Endocrinology. 2001 Oct;142(10):4189-94 - PubMed
  54. Diabetes. 2009 Mar;58(3):550-8 - PubMed
  55. Diabetologia. 2003 Jan;46(1):48-52 - PubMed
  56. Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1039-44 - PubMed
  57. Exp Mol Med. 2007 Apr 30;39(2):222-9 - PubMed
  58. PLoS Med. 2007 May;4(5):e154 - PubMed
  59. Diabetologia. 2005 May;48(5):849-55 - PubMed
  60. Mol Cell. 2010 Jun 25;38(6):864-78 - PubMed
  61. Int J Biochem Cell Biol. 2005 Oct;37(10):2047-63 - PubMed
  62. Cell. 2003 Apr 18;113(2):159-70 - PubMed
  63. Domest Anim Endocrinol. 2002 Apr;22(2):91-102 - PubMed
  64. Nucleic Acids Res. 2010 Nov;38(21):7458-71 - PubMed
  65. Endocr Rev. 2006 Dec;27(7):762-78 - PubMed

Publication Types